| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.6% | |
| Div Cover | 1.6 | |
| Op Mrgn | 18.2% | |
| ROCE | 23.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 25.0 | |
| PEG | n/a | |
| Pr/Revenue | 3.7 | |
| Pr/Book | 3.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 5.7% | |
| PBT | 20.7% | |
| EPS | -51.4% | |
| DPS | 7.1% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 43,075.00 | 8,211.00 | 4.01¢ | 3,512.1 | n/a | -98% | 1.84¢ | 0.0% |
| 31-Dec-22 | 43,653.00 | 8,306.00 | 394.00¢ | 27.9 | 0.0 | +9,732% | 192.00¢ | 1.7% |
| 31-Dec-23 | 40,109.00 | 6,664.00 | 328.00¢ | 33.6 | n/a | -17% | 208.00¢ | 1.9% |
| 31-Dec-24 | 41,950.00 | 7,013.00 | 767.00¢ | 14.7 | 0.1 | +134% | 224.00¢ | 2.0% |
| 31-Dec-25 | 44,328.00 | 8,466.00 | 373.00¢ | 33.6 | n/a | -51% | 240.00¢ | 1.9% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 50,199.80 | 11,513.22 | 548.34¢ | 17.4 | 0.4 | +47% | 254.21¢ | 0.0% |
| 31-Dec-27 | 54,728.15 | 12,773.37 | 606.14¢ | 15.7 | 1.5 | +10% | 270.75¢ | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Coronavirus 99%-accurate antibody test approved ... | 29-Apr-2020 | ShareCast |
| Answer to whether Covid-19 antibodies confer imm... | 23-Apr-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 95.40 |
| Change Today | $ 3.22 |
| % Change | 3.49 % |
| 52 Week High | $136.62 |
| 52 Week Low | $82.56 |
| Volume | 10,644,582 |
| Shares Issued | 1,736.60m |
| Market Cap | $165,672m |
| RiskGrade | 113 |
| Strong Buy | 12 |
| Buy | 6 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 24 |

| Time | Volume / Share Price |
| 16:03 | 1,400,350 @ $95.40 |
| 15:59 | 210 @ $95.40 |
| 15:59 | 100 @ $95.40 |
| 15:59 | 200 @ $95.40 |
| 15:59 | 210 @ $95.40 |
You are here: research